Andrew Saik is recorded as CFO at Arvinas, Inc. (ARVN) and CFO at Yarrow Bioscience, Inc. (YARW) since March 23, 2020. Arvinas, Inc. reported in an 8-K filed June 24, 2024 that Andrew Saik was appointed chief financial officer, treasurer and principal financial officer, effective June 24, 2024. The proxy statement of Arvinas, Inc. reports total compensation of $3,362,314 for Andrew Saik in fiscal 2025, including a base salary of $542,063. Disclosed compensation is on record for 4 fiscal years. Andrew Saik has spoken on 9 earnings calls across 2 companies, most recently for Arvinas, Inc. on August 4, 2026. Those appearances were for Arvinas, Inc. (ARVN) and Yarrow Bioscience, Inc. (YARW). Arvinas, Inc. is classified in the Biotechnology industry within the Healthcare sector. Yarrow Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arvinas, Inc. includes Randy Teel, Ph.D. (CEO and Board Member), Briggs Morrison, M.D. (Chairman), Randy Teel (CFO) and 7 others.
“On June 22, 2024, the board of directors of Arvinas, Inc., a Delaware corporation (the “Company”), appointed Andrew Saik as the Company’s chief financial officer, treasurer and principal financial officer, effective June 24, 2024.”
Arvinas, Inc. Form 8-K, filed June 24, 2024
· Read the filing
Andrew Saik on recent calls
“I'm pleased to provide financial highlights for the second quarter 2026 as a reminder detailed financial results for the second quarter are included in the press release we issued this morning reiterating the team sentiment we have much to look forward to later this year and are pleased with our strong financial…”
“I'm pleased to provide financial highlights for the first quarter, and full year ended March 31, 2026. As a reminder, detailed financial results for the first quarter are included in the press release we just issued this morning.”
“I am pleased to provide financial highlights for the fourth quarter and full year ended 12/31/2025. As a reminder, detailed financial results for the fourth quarter and year-end, including a reconciliation of GAAP to non-GAAP financial measures, are included in the press release we issued this morning.”
“I'm pleased to share financial highlights for the first quarter ended March 31, 2025. As a reminder, detailed financial results for the first quarter are included in the press release we issued this morning.”
“I’m pleased to share financial highlights for the fourth quarter and full year ended December 31, 2024. As a reminder, detailed financial results for the fourth quarter and year end are included in the press release we issued this morning.”
